glp-1 neuroendocrine tumor Survival Benefits of Receptor Agonists in Patients with Neoplasms: A Large-Scale Propensity-Matched Cohort Study Representative images with Ki-67-labeling index

[DOI] [PubMed] [Google Scholar] 123.Lee C.H., Jeon S.J., Cho K.S., Moon E., Sapkota A., Jun H.S., Ryu J.H., Choi J.W

The therapeutic landscape for MASLD is undergoing substantial transformation with emerging incretin-derived therapeutics

[DOI] [PMC free article] [PubMed] [Google Scholar] 138.Linnemann AK, Neuman JC, Battiola TJ, Wisinski JA, Kimple ME, Davis DB

Das biologische Dilemma: Unser Krper ist evolutionr darauf programmiert, Gewichtsverlust als Bedrohung zu interpretieren

For men with obesity-associated functional hypogonadism, these medications offer a fertility-preserving therapeutic option

Code availability All codes described in the manuscript are available upon reasonable request to the corresponding authors